November 21, 2026

Beximco Pharma, Infusions eye merger as new growth strategy

The High Court Monday directed Beximco Pharmaceuticals and Beximco Infusions to hold an extra-ordinary general meeting on June 2 to get approval of their shareholders for an ambitious 'amalgamation scheme'.

bdnews24.com News Service

bdnews24.com

Published : 01 May 2005, 06:00 PM

Updated : 17 Aug 2022, 08:35 PM

Dhaka, May 2 (BDNEWS) - The High Court Monday directed Beximco Pharmaceuticals and Beximco Infusions to hold an extra-ordinary general meeting on June 2 to get approval of their shareholders for an ambitious 'amalgamation scheme'. The High Court directive followed an application filed on April 30, 2005 by the companies to clear way for merger of the two leading pharmaceuticals heavyweights of the country. Citing the example of the merger between Sanafi and Aventis that created a huge pharmaceutical entity in the world, Salman F Rahman, deputy chairman of Beximco Group, explained the benefits of mergers and acquisitions as a growth strategy. "The pharmaceutical industry is a 'mergers-and-acquisitions' favourite, with transactions crossing $80 billion globally last year," he said. The key drivers include geographical synergy for new products and markets, synergy of similar cadre of products, economy, diversification into new areas, catapulting market share and even stemming competition, Salman said. He said Bangladesh is well positioned as a preferred pharmaceutical manufacturing destination given the change in lifestyles, a greater per capita expenditure on medicines, higher processing and re-engineering skills, low manufacturing costs and quick adaptation to new technology. "The merged company will benefit from improved organisational capability, arising from the combination of people from the two companies, proposed for merger, who have diverse skills, talent and vast experience in an increasingly competitive environment," said Beximco Pharmaceuticals Chief Executive Officer (CEO) Nazmul Hassan, also CEO of Beximco Infusions. He said the merger will also rationalise overhead costs, use of raw-material and human resources ensuring 'value for money' by reducing cost and improving efficiency. Such a merger will not only result in a formation of a major company in terms of asset base, revenue and profits, but will also ultimately benefit shareholders through maximisation of their returns, he said. BDNEWS/1822 hrs
Related Stories